Junli Sun
Zhengzhou University
9 Papers
Junli Sun is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Actively implementing an evidence-based feeding guideline for critically ill patients (NEED): a multicenter, cluster-randomized, controlled trial
Jiajia Lin,Gordon S. Doig,Arthur R. H. van Zanten,Yang Wang,Zhongheng Zhang,Tao Chen,Lixin Zhou,Dong-po Jiang,Jiandong Lin,Yafeng Liang,Junli Sun,Wenming Liu,Zhen Yang,Rumin Zhang,An Zhang,Zhigang Zhou,Yang Liu,Fei Tong,Aijun Pan,Xiaobo Huang,Chuming Fan,Weihua Lu,Wei Li,Liming Gu,Yingguang Xie,Feng Guo,Lin Han,Lihua Zhou,Xiangde Zheng,Feng Shan,Yan Qu,Lian-di Li,Zhiqiang Zou,Yan Gao,Chunli Yang,Xijing Zhang,Jinglan Wu,Weixing Zhang,Yuan Zong,Bingyu Qin,Zhe Zhai,Ping Chang,Bo-yao Yu,Min Yu,Shiying Yuan,Bin Zang,Yuan-Fei Li,Fachun Zhou,Xiaomei Chen,Ming-Ju Wu,Yimin Li,Qian Guo,Yunlin Song,Kejian Qian,Xue-yan Liu,Zhiping Li,Cheng Sun,Zhongzhi Tang,Biao Ma,Zhi-Jie He,Lu Ke,Zhihui Tong,Weiqin Li,Yan Wang,Juan Xing,Zhong Wu Zhang,Fengjuan Guo,Lixin Zhou,Qindong Shi,Jun Lu,Ai-Bin Cheng,Peiyang Gao,Wei Xing,Anghui Zhang,Zhigang Zhou,Ting-Ting Zhou,Yang Liu,Fei Tong,Qiuhui Wang,Xiaobo Huang,Dongwu Shi,Wei Wang,Wei Li,Yingguang Xie,Rongqing Sun,Xi Gui Zheng,Jianbo Liu,Y. Ai,Yanling Qu,Hailing Li,Zhiguo Pan,Dong Xu,Zhi-ye Zou,Yan Gao,Qiuye Kou,Xijing Zhang,Chuanyun Qian,Minjie Zhang,Yongjian Feng,Fusen Zhang,Yun Sun,P. Chang,Bo Yu,Min Yu,Yijun Deng,Liyun Zhao,Yuan-zhong Li,M. Shao,Wei Wu,Ming Wu,Zhao Wu Zhang,Yimin Li,Qiang Guo,Zhiyong Wang,Yuanqi Gong,Yunlin Song,Baocai Fu,Chuanyong Gong,Jian Yu,Zhong Tang,Linxi Huang,Biao Ma,Zhijie He,Qingshan Zhou,Rongguo Yu +124 more
TL;DR: In this article , the authors developed an evidence-based feeding guideline for nutrition therapy in critical illness and conducted a large-scale, sufficiently powered study to ascertain the effects of guideline implementation on patient-centered outcomes.
Immune enhancement in patients with predicted severe acute necrotising pancreatitis: a multicentre double-blind randomised controlled trial
Wenjian Mao,Yin Zhu,Hong Mei,Vikesh K. Singh,James Buxbaum,Gordon S. Doig,C He,Weili Gu,Weihua Lu,Haibin Ni,Xiangyang Zhao,Weiwei Chen,Jing-chun Song,Jingyi Wu,He Zhang,Jiajia Lin,Baiqiang Li,J. Windsor,Lu Ke,Jing Zhou,Mingfeng Huang,Longxiang Cao,M Lu,Yan Chen,Gang Li,Bo Ye,Zhihui Tong,Yuxiu Liu,Weiqin Li,Tao Chen,Fang Shao,Nonghua Lv,Liang Xia,Wenhua He,Zhenping Chen,Xinting Pan,Qingyun Zhu,Youdong Wan,Kang Li,Miao Chen,Hongyi Yao,Zigui Zhu,Jin-Yin Wu,Feng Zhou,Shumin Tu,Long Fu,Bing Xue,Xiaofei Huang,Da-peng Zhou,Guoxiu Zhang,Lening Ren,Dahuan Li,Wei Hui Zhao,Xiaomei Chen,Junli Sun,Keke Xin,Wei Chen,Qingcheng Xu,Q. Zeng,Mingjing Shao,Dong Ning Zhao,Jianfeng Tu,Hong-Guo Yang,Bin Wu,H. Ye,Mingzhi Chen,Yingjie Chen,Mei Yang,Hong Gao,Qiang Li,Lijuan Zhao,Guo-hai Chen,Yafei Li,Honghai Xia,Dongliang Yang,Shusheng Zhou,Jiyan Lin,Siyao Liu,Donghuang Hong,Songjing Shi,Zuozheng Wang,Weijie Yao,Yi Sun,Kaixiu Qin,Shanda Xu,Lei Yu,Feng Guo,Yongjun Lin,Yun Zhou,Qing‐ping Jiao,Quanxin Feng,Zhiyong Li +91 more
TL;DR: In this article , the authors evaluated whether early immune-enhancing Thymosin alpha 1 (Tα1) treatment reduces the incidence of acute necrotising pancreatitis (ANP) in patients with predicted severe ANP.
Disulfiram: A Food and Drug Administration-approved multifunctional role in synergistically drug delivery systems for tumor treatment.
TL;DR: In this article , the authors summarized the current limitation and future directions of DSF-based drug delivery systems in the field of tumor therapy, and discussed the current limitations and future development of more advanced drug delivery system.
9
Expression and significance of HMGB1 in patients with sepsis and effects on prognosis
Keke Xin,Junli Sun,Ping Liu,Jianlin Ge,Chenghui Leng,Feng Pang +5 more
- 03 Mar 2020
TL;DR: This study explored the expression of high mobility group box 1 protein (HMGB1) expression in patients with sepsis and its effects on immune function and prognosis and found no significant changes in immune function or prognosis.
3
Association between pretreatment lymphocyte count and efficacy of immune-enhancing therapy in acute necrotising pancreatitis: a post-hoc analysis of the multicentre, randomised, placebo-controlled TRACE trial
Lu Ke,Wenjian Mao,Fang Shao,Jing Zhou,Minyi Xu,Tao Chen,Yuxiu Liu,Zhihui Tong,J. Windsor,Peng-lin Ma,Weiqin Li,He Zhang,Jiajia Lin,Mengjie Lu,Yan Shao Chen,Mingming Ma,Gang Li,Bo Ye,Baiqiang Li,Nonghua Lv,Yinbin Zhu,Liang Xia,Wenhua He,Zhenping,Chen,Xinting Pan,Qingyun Zhu,Youdong Wan,Hong Mei,Kang Li,Miao Chen,C He,Hongyi Yao,Zigui Zhu,Weili Gu,Weihua Lu,Jingyi Wu,Feng Zhou,Shumin Tu,Long Fu,Bing Xue,Haibin Ni,Xiaofei Huang,Dandan Zhou,Guoxiu Zhang,Lening Ren,Dahuan Li,Xiangyang Zhao,Wei Zhao,Xiaomei Chen,Junli Sun,Keke Xin,Wei Chen,Qingcheng Xu,Jing-chun Song,Q. Zeng,Mingjing Shao,Dongsheng Zhao,Jianfeng Tu,Hong-Lǜe Yang +59 more
TL;DR: Wang et al. as mentioned in this paper found that the efficacy of immune-enhancing thymosin alpha 1 (Tα1) therapy on the incidence of acute necrotising pancreatitis may be associated with pretreatment lymphocyte count.
2